Skip to main content
      RT @MeralElRamahiMD: OP0227: Efficacy of Deucravactinib for PsA?
      ⭐️Deucrav = TYK2i.
      ⭐️Dr. Mease et al show MDA

      Meral K. El Ramahi, MD MeralElRamahiMD

      4 years 5 months ago
      OP0227: Efficacy of Deucravactinib for PsA? ⭐️Deucrav = TYK2i. ⭐️Dr. Mease et al show MDA by wk16 + stat. signif improv in ACR20/50/70, enthes, & dactyl w/ deucrav vs PBO in pts w/ active PsA. ⭐️Incl crit: failed at least 1 csDMARD/NSAID/GC & up to 1 TNFi #EULAR2021 @Rheumnow https://t.co/1jjsZIODFV
      RT @Yuz6Yusof: #SLE and #Sjogren: is there a path for these to converge? Dr Martin-Guttierez used #MachineLearning to an

      Md Yuzaiful Md Yusof Yuz6Yusof

      4 years 5 months ago
      #SLE and #Sjogren: is there a path for these to converge? Dr Martin-Guttierez used #MachineLearning to analyse blood & identified 2 endotypes. Both had different trajectory in disease activity & damage. May be useful to stratify appropriate therapy #EULAR2021 #POS0174 @RheumNow https://t.co/R4NMDJYVbY
      RT @Janetbirdope: Better pics re JAKi retention better than bDMARDs in RA. But single site, ? Selection bias. Curves spr

      Janet Pope Janetbirdope

      4 years 5 months ago
      Better pics re JAKi retention better than bDMARDs in RA. But single site, ? Selection bias. Curves spread after 1st yr of Rx. Findings same if only 1st line adv Rx or adjusted for line of therapy POS0205 #EULAR2021 @RheumNow https://t.co/6HYpgVeyiw https://t.co/5mjpUFfWoG
      RT @RichardPAConway: Dr Eder reports population-based, matched cohort study 3 million people. IMID associated ⬆️ hos

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Eder reports population-based, matched cohort study 3 million people. IMID associated ⬆️ hospitalisation in COVID-19. OR 1.23, 95% CI 1.10, 1.37 @RheumNow #EULAR2021 Abstr#OP0285 https://t.co/KDK5j1Gg0X
      RT @uptoTate: Dr. Laura Coates discusses "what is fatigue" based on clinical outcome and disease activity measures in Ps

      Dr. Rachel Tate uptoTate

      4 years 5 months ago
      Dr. Laura Coates discusses "what is fatigue" based on clinical outcome and disease activity measures in PsA. Three main groups stood out in predicting fatigue in these patients: level of inflammation, chronic pain, and chronicity of PsA disease. #EULAR2021 @RheumNow https://t.co/pFYRb1X7pT
      RheumNow’s expanded coverage of the #EULAR2021 Annual meeting is sponsored in part by Novartis, Bristol Myers Squibb,

      Dr. John Cush RheumNow

      4 years 5 months ago

      RheumNow’s expanded coverage of the #EULAR2021 Annual meeting is sponsored in part by Novartis, Bristol Myers Squibb, and Janssen. All content chosen by RheumNow and its faculty.

      During Day 2 there were great sessions devoted to RA, spondylarthritis, fatigue and more.  Here are some of my highlights from Day 2.
      RT @Janetbirdope: JAKi to #JAKi cycling is common in #rheumatoidarthritis Rx. Opal registry >53000 pts, 1/4 treated w

      Janet Pope Janetbirdope

      4 years 5 months ago
      JAKi to #JAKi cycling is common in #rheumatoidarthritis Rx. Opal registry >53000 pts, 1/4 treated with JAKi (4000) & 44% new starts were Jaki. JAKi to JAKi cycling was >40%! POS0223 #EULAR2021 ⁦@RheumNow⁩ https://t.co/XV7wVJsE9c
      RT @uptoTate: "What we really need in SpA/PsA is personalized medicine in order to choose the best drug MOA for our pati

      Dr. Rachel Tate uptoTate

      4 years 5 months ago
      "What we really need in SpA/PsA is personalized medicine in order to choose the best drug MOA for our patients." Dr. Laura Coates addressing paradox of choice in treatment options. I remain hopeful for better biomarkers for future precision medicine approach. #EULAR2021 @RheumNow https://t.co/nIDksfTe7h
      Turning the Corner on CV Risk in Rheumatoid Arthritis by Richard Conway ( @RichardPAConway) #EULAR2021

      https://t.co/S0o

      Dr. John Cush RheumNow

      4 years 5 months ago
      Turning the Corner on CV Risk in Rheumatoid Arthritis by Richard Conway ( @RichardPAConway) #EULAR2021 https://t.co/S0ownscRKv https://t.co/PJODe0U6wr
      ×